←
Ankit Kalucha45 posts
Ankit Kalucha avatar

Ankit Kalucha

@Ankitowledge

Easing oncology outcomes decision making

◷ Joined December 2023▧ 13 Photos and videos
Ankit Kalucha avatar
Ankit Kalucha@Ankitowledge·Jun 21

The other side of ASCO 2026. Used Gen AI to synthesize ASCO 2026 KOL negative commentary into a simple signal map.

Post attachmentPost attachmentPost attachment
ASCO avatar
⟳ Ankit Kalucha retweeted
ASCO@ASCO·22 Aug 2025

NEW ASCO Guidelines Assistant tool leverages Google Cloud Vertex AI platform & Gemini models, enabling oncology clinicians to quickly access evidence-based clinical guidelines.

Giannis Mountzios avatar
⟳ Ankit Kalucha retweeted
Giannis Mountzios@g_mountzios·22 Jun 2025

Immune cell effector-associated neurotoxicity syndrome (ICANS) is a less well understood entity related to cytokine disruption of BBB and comprising diverse neurological symptoms. ICANS was rare (<10%) and no ICANS 3 or more was observed. (pic from Sands Cancer 2024) 🧵12/15

Post attachment
Yakup Ergün avatar
⟳ Ankit Kalucha retweeted
Yakup Ergün@dr_yakupergun·20 Sep 2024

Biomarkers, Molecular Targets, and Methods of Detection for Precision Medicines in NSCLC (ESMO guideline)

Post attachment
Katsuaki Maehara 🇯🇵 avatar
⟳ Ankit Kalucha retweeted
Katsuaki Maehara 🇯🇵@KatsuakiMaehara·16 Sep 2024

🫁 NCCN guideline updated 🫁 🫁 Part-1, NSCLC 🫁 🌟 Version 9.2024 — September 9, 2024 🌟 📌 Ver. 8 was updated on August 23, 2024, so went to ver. 9 in about 2 weeks, right in the middle of WCLC 2024.

Post attachmentPost attachment